07:15 AM EDT, 08/12/2025 (MT Newswires) -- Centessa Pharmaceuticals ( CNTA ) reported a Q2 loss Tuesday of $0.38 per diluted, compared with a loss of $0.40 a year earlier.

Four analysts polled by FactSet expected a loss of $0.35.

As expected, the company did not report any revenue for the quarter ended June 30.

At the end of the quarter, the company said it has cash, cash equivalents and investments of $404.1 million, which it said will be able to fund operations into mid-2027.